Join hosts Mark Gramling and Bruno Larvol as they navigate through the complexities of hazard ratio, a cornerstone statistic in oncology studies. Hazard ratio serves as a powerful tool for assessing the relative risk of an event occurring between two groups, such as patients receiving different treatments or exposed to varying risk factors.In this enlightening discussion, we explore how hazard ratio influences decision-making in cancer research and treatment. From its interpretation in survival analysis to its implications for treatment efficacy and patient outcomes, we'll uncover the profound impact of hazard ratio on shaping the landscape of oncology.With insights from leading experts and real-world examples from recent studies and clinical trials, this episode provides a comprehensive understanding of hazard ratio and its significance in advancing our knowledge of cancer.Whether you're a healthcare professional, researcher, or simply passionate about staying informed on the latest developments in oncology, this episode promises to deepen your understanding of hazard ratio and its role in improving patient care.

Ver todos los episodios